At least Capricor Therapeutics (CAPR) is staying happy…
What’s up with Capricor Therapeutics?
Capricor Therapeutics (CAPR) opened at $6.97, which means the stock is down 0.73% from yesterday’s closing price of 6.85. Today, the company has a high of $7.30 and a low of $6.60. The company has a market cap of $84.755 million with a 52-week high of $11.08 and a 52-week low of $0.88.
What about the future forCapricor Therapeutics
The high forecast for Capricor Therapeutics is 10.00 while the low is 9.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Capricor Therapeutics has a weak forecast. A weak forecast is due to the company posting consistent losses in their earning reports. The future outlook does not seem too bright as this could potentially cause the company to file for bankruptcy.. Based on this information CAPR seems to be a risky buy.
About Capricor Therapeutics
Capricor Therapeutics, Inc. operates as a clinical stage biotechnology company. The Company focuses on the development and commercialization of biological therapies for the treatment of duchenne muscular dystrophy (DMD) and other rare disorders.